Name: CJC-1295 (with DAC) – 2mg
Brand: CertPeptides
SKU: CP-CJC1295-2MG
Price: 44.99 USD
Availability: InStock

Product Description

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). It is a modified form of GRF(1-29) — the first 29 amino acids of GHRH — engineered with four amino acid substitutions to resist enzymatic degradation, and conjugated with a lysine-linked maleimidopropionic acid (MPA) group that binds to serum albumin, significantly extending its biological half-life. This modification allows for sustained elevation of growth hormone levels in research models, making it a valuable tool for studying the GH/IGF-1 axis and metabolic pathways.

Specifications

Molecular Weight	3367.97 g/mol
Sequence	Modified GRF(1-29) with Drug Affinity Complex
Purity	≥99% (HPLC)
Physical Form	Lyophilized powder
Storage	-20°C, keep away from light and moisture

Research Applications

Growth hormone secretion and GH/IGF-1 axis studies
GHRH analog and receptor binding research
Metabolic pathway and body composition research
Sustained-release peptide pharmacokinetic studies

Disclaimer: This product is intended for laboratory and research use only. Not for human or animal consumption. All handling should be conducted by qualified researchers in accordance with applicable regulations.

Certificate of Analysis

Every batch of CJC-1295 sold by CertPeptides is independently tested by a third-party laboratory. The Certificate of Analysis (COA) confirms identity, purity (≥99% via HPLC), and the absence of heavy metals and microbial contamination.

A COA is included with every order. You may also request a batch-specific COA through our contact page.

Laboratory Product Information

📦 Includes

One (1) vial of CJC-1295 DAC lyophilized powder (2mg per vial), Certificate of Analysis (COA).

🔬 Purpose

CJC-1295 is a synthetic analog of growth hormone–releasing hormone (GHRH, residues 1–29) incorporating amino acid substitutions for enhanced stability. The Drug Affinity Complex (DAC) modification enables albumin binding. It is used in in-vitro GHRH receptor binding and cAMP reporter assays.

🧬 Ingredients

CJC-1295 with DAC (Drug Affinity Complex), modified GHRH(1–29) analog, ≥99% purity (HPLC verified). No fillers, binders, or excipients.

🔬 Laboratory Handling Information

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂ (base peptide; DAC adds ~280 Da)
Molecular Weight: ~3647 Da (with DAC); ~3368 Da (without DAC)
Amino Acid Sequence: Modified GHRH(1–29)-NH₂: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ with D-Ala², Gln⁸, Ala¹⁵, Leu²⁷ substitutions and DAC moiety
Solubility: Soluble in sterile aqueous buffers (e.g., bacteriostatic water, PBS) at concentrations suitable for in-vitro applications
Storage: Store lyophilized product at 2–8°C; reconstituted aliquots at −20°C; avoid repeated freeze-thaw cycles
Literature Reference: Referenced at 1–100 nM for in-vitro GHRH receptor binding and cAMP reporter gene assays (PubMed: Teichman et al., Endocr Rev, 2006)

🚨 IMPORTANT — RESEARCH USE ONLY

FOR RESEARCH USE ONLY – NOT FOR HUMAN OR VETERINARY CONSUMPTION. Not intended for any in vivo use, therapeutic, or diagnostic purpose. No dosing or administration information provided or implied.

🚚 Shipping

Ships in temperature-controlled packaging via priority courier. Most orders ship within 24 hours on business days. Free shipping on orders over $150. Tracking number provided via email upon shipment.

CJC-1295 (with DAC) – 2mg